Real Time PCR Kit for SARS - CoV - 2 / COVID - 19
Bihar Medical Services And Infrastructure Corporation Limited (bmsicl)
Progress
Quantity
500
Bid Type
Two Packet Bid
Central Health Service, under the Department of Health And Family Welfare, invites bids for a Real Time PCR Kit for SARS-CoV-2 / COVID-19 for delivery within Delhi. The scope encompasses the supply of in-vitro diagnostic kits with specified performance metrics, batch documentation, and regulatory compliance. The contract requires MDR 2017 compliance, valid drug license, and manufacturing unit certification, with attached test reports for each batch. The option clause allows up to 50% quantity variation, and the buyer emphasises integrity pact compliance and end-user certificate alignment. The EMD is ₹5,250, indicating a moderate-scale procurement, and the project targets timely supply to state health facilities in New Delhi. Emphasis on shelf life and minimum shelf life at delivery ensures product viability.
Product: Real Time PCR Kit for SARS-CoV-2 / COVID-19
Detection: in-vitro; fluorescent probe-based detection
Gene targets: specified per kit (number to be clarified in BOQ/toolkit)
Reaction: RT-PCR compatible with standard real-time systems
Controls: per pack; documented interpretation and cycle information
Shelf life: months from manufacture; minimum shelf life at delivery
Certifications: MDR 2017 compliance; drug license under Drugs and Cosmetic Act; manufacturing unit certification
Documentation: detailed principle, methodology, validity criteria, dye, storage, biosafety statements
Batch testing: test reports for each batch as per MDR 2017
Delivery: supply-only; risk management with end-user document if required
EMD ₹5,250; bid security to be furnished as per tender rules
Quantity may fluctuate up to 50% during ordering and currency of contract
Make in India authorization certificate required; MSME/NSIC exemptions if applicable
End User Certificate provided via buyer format on request; Integrity Pact mandatory
Delivery schedule tied to PO; GST handled as per actuals with applicable rates
Payment as per buyer policy; GST as actuals; EMD to be retained as bid security until satisfactory performance
Delivery period linked to original PO; extended delivery time for option quantities calculated as (additional/original) × original period, minimum 30 days
Penalties for late delivery to be as per GeM/buyer terms; LD percentage not disclosed in data
Experience in supplying real-time PCR kits to government or PSUs
Valid MDR 2017 compliance and drug license
Manufacturing unit certification and OEM authorization
Three-year average turnover demonstrating financial capacity
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
Real Time PCR Kit for SARS - CoV - 2 / COVID - 19 (Q2)
Advisory Bank
Bank Of Baroda
ePBG Percentage
1%
ePBG Duration (Months)
12
Max Delivery Days
125
Delivery Locations
1
Delivery Cities
South
Delivery Pincodes
110029
| Consignee | Address | City | State | Pincode | Quantity | Delivery Days | Additional Requirement |
|---|---|---|---|---|---|---|---|
| Puneet Arora | 110029,OFFICE OF THE MEDICAL SUPERINTENDENT SAFDARJUNG HOSPITAL NEW DELHI-110029 | South | Delhi | 110029 | - | 125 | - |
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
CATALOG Specification
OTHER
OTHER
GEM_GENERAL_TERMS_AND_CONDITIONS
Bihar Medical Services And Infrastructure Corporation Limited (bmsicl)
Indian Army
N/a
Directorate Of Medical Education & Research
KARNAL, HARYANA
N/A
WEST DELHI, DELHI
Tender Results
Loading results...
| Category | Specification | Requirement |
|---|---|---|
| GENERAL FEATURES | Product Description | Real Time PCR Kit For SARS-CoV-2/COVID-19 |
| PRODUCT INFORMATION | Type of Kit | Real Time Reverse Transcription PCR Kit For SARS-CoV-2/COVID-19 |
| PRODUCT INFORMATION | Detection Type (in-vitro) | Quantitative |
| PRODUCT INFORMATION | Testing Principle | One-step RT-PCR |
| PRODUCT INFORMATION | Number of viral gene targets on which test is based | At-least 2 or more genomic SARS-CoV-2 specific genes |
| PRODUCT INFORMATION | Type of Reaction | Multiplex Reaction |
| PRODUCT INFORMATION | No cross reactivity | Yes |
| PRODUCT INFORMATION | Species Reactivity | Human |
| PRODUCT INFORMATION | Test compatible with | Suitable for in-vitro qualitative detection of SARS-CoV-2 nucleic acids in throat (oropharyngeal) swabs, nasopharyngeal swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal washes, nasal aspirates and broncho alveolar lavage fluid (BALF) from individuals who are suspected of COVID-19 |
| PRODUCT INFORMATION | Result Time | ≤ 90 minutes Or higher |
| PRODUCT INFORMATION | Sensitivity | ≥ 95% Or higher |
| PRODUCT INFORMATION | Specificity | ≥ 99% Or higher |
| PRODUCT INFORMATION | Reagent included in the kit | Primer, Probe, enzymes |
| PRODUCT INFORMATION | Control provided with each pack of kit | Internal control which validates sample quality, RNA extraction and RT-PCR reaction |
| PRODUCT INFORMATION | Type of Fluorescent Probe used for the detection | RT-PCR Kit for detecting SARS-CoV-2 uses fluorescent probe based TaqMan chemistry with multiplex reactions in a single tube. Probes have have reporter dyes in the range of spectral separation to have compatibility with common RT-PCR machines available. Probe for each gene should have separate dye/fluorophore so that the result for each gene can be read individually |
| PRODUCT INFORMATION | Compatibility with Real Time PCR System | Closed |
| PRODUCT INFORMATION | Document detailing principle,component,methodology,validity criteria,result interpretation,cycle information,gene name,respective dye used,performance characteristic,biosafety,assay limitation,storage condition,mfg & exp date,disposal method provided | Yes |
| CERTIFICATIONS & REPORTS | Compliance to Medical Device Rules (MDR) 2017 as amended till date | Yes |
| CERTIFICATIONS & REPORTS | Availability of valid drug license for the product issued from the competent authority defined under Drugs and Cosmetic Act 1940 and Rules made there under as amended till date | Yes |
| CERTIFICATIONS & REPORTS | Manufacturing unit certification | ISO:13485 (Latest) |
| CERTIFICATIONS & REPORTS | Availability of Test Report for each supplied batch/product as per Medical Device Rules (MDR) 2017 as amended till date | Yes |
| CERTIFICATIONS & REPORTS | Submission of all necessary certifications, licenses and test reports to the buyer at the time of bid submission and along with supplies as per buyer requirement | Yes |
| SHELF LIFE | Shelf life from the date of manufacture (in months) | 24 Or higher |
| SHELF LIFE | Minimum shelf life of the product at the time of delivery to the consignee | 3/4 th of total shelf life |
Discover companies most likely to bid on this tender
GST certificate
PAN card
Experience certificates for government/PSU or reputed private buyers
Audited financial statements or CA certificate confirming three-year turnover
EMD submission document (₹5,250) via DD/online
MDR compliance certificate and drug license validity
Manufacturing unit certification
Test reports per MDR for each batch
OEM authorization and Make in India authorization
Signed Integrity Pact
End User Certificate (if requested by buyer)
Key insights about DELHI tender market
To bid, submit MDR 2017 compliance documents, valid drug license, and manufacturing certificate. Include EMD ₹5,250, Make in India authorization, OEM authorizations, and batch test reports. Ensure three-year turnover proof and signed Integrity Pact; delivery terms align with PO timelines and 50% quantity option.
Required documents include GST certificate, PAN card, audited financial statements or CA certificate for turnover, MDR compliance certificate, drug license, manufacturing unit certification, test reports per MDR, OEM authorization, Integrity Pact, and EMD receipt. End User Certificate may be requested in buyer format.
Key specs include in-vitro detection with fluorescent probe, reference to batch test reports, shelf life in months from manufacture, compatibility with standard Real Time PCR systems, and documentation detailing principle, gene targets, dye used, and disposal. Cross-reactivity not allowed and exact gene targets per kit must be clarified in bid.
Delivery scope is supply-only; quantity may vary up to 50% at award and during currency. Delivery period is adjusted proportionally using ((additional quantity / original quantity) × original delivery period), with a minimum of 30 days. Ensure readiness for scaled orders and stock management.
Bidders must provide Make in India authorization certificate to participate. If MSME/NSIC exemption applies, include exemption certificate. Ensure MDR compliance, drug license, and manufacturing unit certification to meet buyer requirements for government procurement in Delhi.
EMD paid as ₹5,250 to secure bid submission. Turnover must meet the three-year average threshold specified in the bid document, supported by audited balances or CA certificate. Solid financial standings help ensure eligibility for supply to government buyers.
Indian Institutes Of Science Education And Research (iiser)
📍 THIRUVANANTHAPURAM, KERALA
N/a
📍 KAMRUP, ASSAM
All India Institute Of Medical Sciences (aiims)
📍 JODHPUR, RAJASTHAN
All India Institute Of Medical Sciences (aiims)
📍 JODHPUR, RAJASTHAN
National Institute Of Ayurveda
📍 JAIPUR, RAJASTHAN
Sign up now to access all documents
Main Document
CATALOG Specification
OTHER
OTHER
GEM_GENERAL_TERMS_AND_CONDITIONS